Gravitate Health FHIR Implementation Guide (FHIR R4)
0.1.0 - CI Build

Gravitate Health FHIR Implementation Guide (FHIR R4), published by . This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health-ips/ and changes regularly. See the Directory of published versions

Example Bundle: Pedro Gravitate's IPS

id: gravitate-Pedro
Composition status: final
Composition Type: Patient summary Document
Subject:
identifier: Pedro-1
Name: Pedro Gravitate
active: true
gender: male
Birth Date: 1980-10-05

Sections

Problem List

Condition: Depressive disorder (disorder) (35489007)
clinicalStatus: active
Condition: Human immunodeficiency virus infection (86406008)
clinicalStatus: active
asserter: Dr. Xavier García
onsetDateTime: 2018
Condition: Irritable bowel syndrome (10743008)
clinicalStatus: active

Medication Summary

Medication: Dovato 50 mg/300 mg (Dolutegravir/ Lamivudine) tablets
status: active
Medication Detail:
  • System https://spor.ema.europa.eu/pmswi Code: EU/1/19/1370/001 [Dovato 50 mg/300 mg 30 tablets]
  • System https://www.who-umc.org/phpid Code: 0x073AF2E5B92AE19E8B67635AFFB3D6CA [lamivudine and dolutegravir, 300 mg/50 mg, tablets]
  • System http://snomed.info/sct Code: 787165000 [Dolutegravir- and lamivudine-containing product in oral dose form]
  • System http://www.whocc.no/atc Code: J05AR25 [lamivudine and dolutegravir]
Dose Form: Coated tablet
Ingredient: lamivudine (http://fdasis.nlm.nih.gov#2T8Q726O95)
strength: 300 mg/1 Tablet
Ingredient: dolutegravir (http://fdasis.nlm.nih.gov#DKO1W9H7M1)
strength: 50 mg/1 Tablet
Route: Oral use
Medication: Mirtazapine 30 mg Coated Tablet
status: active
Medication Detail:
  • System https://spor.ema.europa.eu/pmswi Code: 67.068 [MIRTAZAPINA CINFA 30 mg Coated Tablet]
  • System https://www.who-umc.org/phpid Code: 0x6c47381b040e5b588db23b2272f28eec [mirtazapine 30 mg, tablets]
  • System http://www.whocc.no/atc Code: N06AX11 [mirtazapine]
Dose Form: Coated tablet
Ingredient: Mirtazapine (http://fdasis.nlm.nih.gov#A051Q2099Q)
strength: 30 g/1 Tablet
Route: Oral use
Medication: CALCIO/VITAMINA D3 ROVI 1000 mg/880 UI COMPRIMIDOS EFERVESCENTES
status: active
Medication Detail:
  • System https://spor.ema.europa.eu/pmswi Code: 68290 [CALCIO/VITAMINA D3 ROVI 1000 mg/880 UI COMPRIMIDOS EFERVESCENTES]
  • System https://www.who-umc.org/phpid Code: 0xF79CABF272B6A7EEF104DDDA44E82716 [Calcium Vitamin D]
Dose Form: Effervescent tablet
Ingredient: Calcium carbonate (http://fdasis.nlm.nih.gov#H0G9379FGK)
strength: 1000 mg/1 Tablet
Ingredient: cholecalciferol (http://fdasis.nlm.nih.gov#1C6V77QF41)
strength: 880 {UI}/1 Tablet
Route: Oral use
Medication: cinitrapide 1 mg
status: active
Medication Detail:
  • System https://spor.ema.europa.eu/pmswi Code: 59.032 [BLASTON 1 mg tablets]
  • System https://www.who-umc.org/phpid Code: 0xbb82cd10ab2add752b2b9224931077b2 [cinitrapide 1 mg tablet]
  • System http://www.whocc.no/atc Code: A03FA08 [Cinitapride]
Dose Form: Tablet
Ingredient: CINITAPRIDE (http://fdasis.nlm.nih.gov#R8I97I2L24)
strength: 1 mg/1 Tablet
Route: Oral use
Medication: Collagen and magnesium supplements
status: active
Medication Detail:
  • System https://spor.ema.europa.eu/pmswi Code: 0xb9846396e9e1eedc4a344e7b64d57107 [AQUILEA ARTICULACIONES COLAGENO Y MAGNESIO 375GR]
Dose Form: Oral powder
Ingredient: MAGNESIUM (http://fdasis.nlm.nih.gov#I38ZP9992A)
Ingredient: HYALURONIC ACID (http://fdasis.nlm.nih.gov#S270N0TRQY)
Ingredient: HUMAN TYPE I COLLAGEN (http://fdasis.nlm.nih.gov#PT3TGI7OIP)
Route: Oral use
Medication: Vitaminc C supplement
status: active
Medication Detail:
  • System https://spor.ema.europa.eu/pmswi Code: 0x173fdc0ef097ed4dbe3915fba2e90586 [SORIA NATURAL VITAMINA C 36 COMPRIMIDOS]
  • System http://www.whocc.no/atc Code: A11GA01 [ascorbic acid (vit C)]
Dose Form: Modified-release tablet
Ingredient: ASCORBIC ACID (http://fdasis.nlm.nih.gov#PQ6CK8PD0R)
Route: Oral use
Medication: Protein supplements
status: active
Medication Detail:
  • System https://spor.ema.europa.eu/pmswi Code: 0x81bb4f17d1ea7aabcd39383d33a4f2d6 [NATURES PLUS SPIRU-TEIN BATIDO PROTEINA SABOR COOKIES 525GR]
Dose Form: Oral powder
Ingredient: SOY PROTEIN (http://fdasis.nlm.nih.gov#R44IWB3RN5)
Route: Oral use